Company attributes
Location
B2X
CEO
Founder
Date Incorporated
2010
Number of Employees (Ranges)
1 – 10
Full Address
CEDEX 11 38 RUE SERVAN 75011, PARIS, ILE-DE-FRANCEFrance
Investors
Founded Date
2010
0Total Funding Amount (USD)
14,436,328
Latest Funding Round Date
December 14, 2021
Former CEO
Latest Funding Type
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
13,000,000
Meiogenix is a French biotech company that holds an exclusive and worldwide license for a technology that modulates the frequency of homologous recombination in eukaryotic cells. This technology facilitates the natural process that introduces genetic diversity in organisms allowing the generation of novel natural varieties with commercial potential.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
